Synektik’s stock falls with reports of Chinese robots in Polish hospitals

Polish investors reacted nervously to news that Chinese surgical robots may enter local hospitals, causing Synektik's stock to fall 15%. The new MP1000 robots from Edge Medical are priced significantly lower than da Vinci systems, for which Synektik holds exclusive distribution rights in Poland and neighboring countries.
Analysts, however, urge caution, citing uncertainty about regulatory approvals and hidden costs in service contracts. While competition may grow, Synektik's market dominance, trained personnel, and recurring revenues from accessories and services remain strengths. Moreover, the EU recently announced restrictions on Chinese medical equipment in large public procurements, responding to trade imbalances with China. This could limit the long-term impact of Chinese rivals in the European medical device market.
(pb.pl)